Novel, needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes Date: May 9, 2025 Source: The University of Hong Kong Summary: A research team ...

The antiviral baloxavir significantly reduced household transmission of influenza compared with placebo. The drug showed consistent effects across age groups, virus types, and countries ...

Australia is reporting high numbers of influenza, respiratory syncytial virus (RSV), and pertussis infections well ahead of winter, with concerns that declining vaccination rates could contribute ...

It is caused by influenza viruses. Symptoms of mild flu infections can resemble those of the common cold, which is also caused by viruses; that said, flu symptoms tend to be more intense than cold ...

The 2024-2025 COVID-19 and influenza vaccines provided protection against ED/UC, outpatient visits, and hospitalizations. In the 2024-2025 season, the COVID-19 vaccine provided additional ...

Flu season is here, and cases of Influenza A and Influenza B are on the rise. While most flu infections cause mild symptoms like fever, body aches, and a sore throat, severe cases of flu can lead ...

Influenza vaccination significantly reduces flu-related morbidity and mortality across all age groups, according to a large-scale Spanish study analyzing data from more than 38 countries and 6.5 ...

Influenza A viruses rapidly adjust their shape when placed in conditions that reduce infection efficiency, such as the presence of antiviral antibodies or host incompatibility.

(NEXSTAR) – The flu is spreading far and wide across the U.S. – and influenza A is largely to blame. Of all the flu tests reported to the Centers for Disease Control and Prevention since the ...

The virus — known as Avian influenza, or H5N1 — is fatal to poultry and makes cows mildly sick with symptoms of lethargy, loss of appetite and dehydration. Although state officials would not ...

The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...